Example: tourism industry
Kerendia Prescribing Information
The safety of Kerendia was evaluated in the randomized, double -blind, placebo- controlled, multicenter pivotal phase 3 study FIDELIO -DKD. In this study, 2827 patients received Kerendia (10 or 20 mg once daily) and 2831 received placebo . For patients in the Kerendia group, the mean duration of treatment was 2.2 years.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: